Novartis Eurax Dermatological Cream 20g 10%
- Brand: EG SpA
- Product Code: 001578018
- Availability: In Stock
- Purchase 3 items for 8.25€ each
- Purchase 4 items for 8.08€ each
- Purchase 5 items for 7.91€ each
Insect bites, itching, rashes or burns circumscribed, eczema.
Contraindications / Side Effects
Hypersensitivity 'to the active substance or to any of the excipients. Infections and skin diseases: tuberculosis, pyoderma, mycoses, so 'as skin ulcers and wounds, skin tumors. The use of the cream and 'contra-on facial skin, anogenital area, on large lesions, infectious diseases (syphilis), viral infections (such as herpes, chicken pox), perioral dermatitis, acne, rosacea, skin reactions after a vaccination, pustular psoriasis. The medicine should not be used in infants and children under 2 years of age '.
Rubbing lightly, spread the cream on the diseased part in a thin layer, twice a day. Do not exceed the recommended dose. The medicine should not be used in children younger 'less than two years.
If the condition worsens or if symptoms persist for more 'than 7 days, terminate the applications and seek medical advice. Avoid contact with eyes. The use, especially if prolonged, of medicinal products for topical use can 'give rise to phenomena of irritation or sensitization. In this case and 'hold treatment and appropriate therapy instituted. Prolonged use of this drug may 'cause telangiectasia and skin atrophy. When used for a long time, or over a wide area of skin, hydrocortisone can 'be absorbed into the blood and exercise activity' systemic. Such event occurs more 'easily if recourse is to occlusion; the diaper can 'act as an occlusive dressing. Systemic absorption of topical corticosteroids may 'determine reversible suppression of the hypothalamic-pituitary-adrenal axis with a potential for glucocorticosteroid insufficiency after discontinuation of treatment. A systemic absorption following topical corticosteroids, some patients may also have manifestations of Cushing's syndrome, glycosuria, hyperglycemia during treatment. Patients applying a topical steroid to a large surface area or in areas with occlusive dressing should be periodically monitored for the suppression of the hypothalamic-pituitary-adrenal axis. When used in the area adjacent to the eyes will take the necessary precautions, since 'the penetration of the medicine into your eyes can' cause glaucoma or cataracts. If this were to happen, the residue of cream should be rinsed with water. The cream contains ethyl parahydroxybenzoate, methyl parahydroxybenzoate and propyl parahydroxybenzoate which may cause allergic reactions (possibly delayed). Paediatric population: do not use in infants and children under 2 years of age '. Particular caution is recommended when using the drug in children because of the risk of systemic exposure hydrocortisone. Since 'the relationship between body surface area and body weight in children and' higher than in adults, children are at increased risk of systemic corticosteroid effects, including suppression of the hypothalamic-pituitary-adrenal axis and Cushing's syndrome than adults . Prolonged use of corticosteroids in children can 'cause growth and developmental disorders. The duration of treatment must be the most 'short as possible and you have to use the most' low dose. And 'appropriate to monitor the growth and development of the child. Use in elderly patients: the elderly may experience more 'marked side effects, especially in cases of co-morbidity', such as osteoporosis, hypertension, hypokalaemia, diabetes mellitus, in addition to the increased susceptibility 'to infections and skin thickness reduction. These people must be carefully monitored to prevent the occurrence of life-threatening reactions. In case of atrophic subcutaneous conditions, especially in the elderly, the product should be used with caution. Use in patients with renal or hepatic impairment: In patients with hepatic or renal insufficiency disease should be used special precautions for use, and 'requires frequent clinical monitoring of health status.
There are no reported cases of interaction and incompatibility 'with other medicines.
The use, especially if prolonged, of topical products can 'give rise to phenomena of irritation or sensitization. In this case and 'hold treatment and appropriate therapy instituted. During the application of the cream can manifest acne, purple steroid-induced, dry skin, hypertrichosis, hypopigmentation of the skin, skin atrophy and striae, telangiectasia, perioral dermatitis, folliculitis, itching. The increased absorption due to the use of an occlusive dressing, can 'cause systemic effects such as edema, hypertension and impairment of the immune system; It may 'also experience suppression of the hypothalamic-pituitary-adrenal axis and Cushing's syndrome, particularly in pediatric patients. Prolonged use of corticosteroids in children can 'cause growth and developmental disorders. Following topical application in the area of the eyelids can occasionally manifest glaucoma or cataracts. The incidence of adverse reactions is not 'known. The reporting of suspected adverse reactions that occur after the authorization of the medicine and 'important, as it allows continuous monitoring of the benefit / risk ratio of the drug.
Pregnancy and lactation
Its use is not 'recommended during pregnancy and lactation.